BioHarvest Sciences Inc. (BHST)
NASDAQ: BHST · Real-Time Price · USD
6.30
+0.02 (0.32%)
Dec 5, 2025, 4:00 PM EST - Market closed
BioHarvest Sciences Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Revenue | 32.72 | 25.19 | 12.67 | 5.5 | 2.1 | 0.4 | Upgrade
|
| Revenue Growth (YoY) | 45.88% | 98.77% | 130.48% | 161.56% | 430.81% | 81.65% | Upgrade
|
| Cost of Revenue | 13.35 | 11.25 | 7.04 | 4.28 | 1.43 | 0.26 | Upgrade
|
| Gross Profit | 19.37 | 13.94 | 5.63 | 1.22 | 0.67 | 0.14 | Upgrade
|
| Selling, General & Admin | 20.1 | 16.13 | 12.23 | 9.52 | 5.03 | 4.44 | Upgrade
|
| Research & Development | 5.41 | 4.8 | 3.37 | 2.31 | 4.13 | 1.26 | Upgrade
|
| Operating Expenses | 25.52 | 20.93 | 15.6 | 11.83 | 9.16 | 5.71 | Upgrade
|
| Operating Income | -6.14 | -6.99 | -9.97 | -10.61 | -8.49 | -5.57 | Upgrade
|
| Interest Expense | -0.92 | -1.24 | -0.94 | -0.51 | -0.81 | -0.5 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.08 | -0.08 | 0.03 | 0.23 | 0.29 | -0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -4.61 | -4.61 | -1.69 | -0.35 | -0.82 | 0.15 | Upgrade
|
| EBT Excluding Unusual Items | -11.74 | -12.91 | -12.56 | -11.24 | -9.83 | -5.99 | Upgrade
|
| Other Unusual Items | - | - | - | - | - | -0.6 | Upgrade
|
| Pretax Income | -11.74 | -12.91 | -12.56 | -11.24 | -9.83 | -6.58 | Upgrade
|
| Income Tax Expense | 0.15 | 0.01 | - | - | - | - | Upgrade
|
| Earnings From Continuing Operations | -11.89 | -12.91 | -12.56 | -11.24 | -9.83 | -6.58 | Upgrade
|
| Net Income | -11.89 | -12.91 | -12.56 | -11.24 | -9.83 | -6.58 | Upgrade
|
| Net Income to Common | -11.89 | -12.91 | -12.56 | -11.24 | -9.83 | -6.58 | Upgrade
|
| Shares Outstanding (Basic) | 17 | 16 | 14 | 13 | 12 | 10 | Upgrade
|
| Shares Outstanding (Diluted) | 17 | 16 | 14 | 13 | 12 | 10 | Upgrade
|
| Shares Change (YoY) | 13.20% | 19.66% | 3.67% | 4.87% | 28.15% | 229.29% | Upgrade
|
| EPS (Basic) | -0.68 | -0.80 | -0.93 | -0.86 | -0.79 | -0.68 | Upgrade
|
| EPS (Diluted) | -0.68 | -0.80 | -0.93 | -0.86 | -0.79 | -0.68 | Upgrade
|
| Free Cash Flow | -9.46 | -9.52 | -10 | -10.5 | -8.43 | -4.05 | Upgrade
|
| Free Cash Flow Per Share | -0.54 | -0.59 | -0.74 | -0.80 | -0.68 | -0.42 | Upgrade
|
| Gross Margin | 59.21% | 55.35% | 44.45% | 22.17% | 31.87% | 34.85% | Upgrade
|
| Operating Margin | -18.77% | -27.75% | -78.65% | -193.02% | -403.95% | -1405.81% | Upgrade
|
| Profit Margin | -36.33% | -51.27% | -99.15% | -204.37% | -467.51% | -1662.63% | Upgrade
|
| Free Cash Flow Margin | -28.90% | -37.79% | -78.88% | -190.92% | -401.24% | -1022.22% | Upgrade
|
| EBITDA | -5.41 | -6.54 | -9.58 | -10.33 | -8.43 | -5.52 | Upgrade
|
| EBITDA Margin | -16.53% | -25.96% | -75.57% | -187.83% | - | - | Upgrade
|
| D&A For EBITDA | 0.73 | 0.45 | 0.39 | 0.29 | 0.07 | 0.05 | Upgrade
|
| EBIT | -6.14 | -6.99 | -9.97 | -10.61 | -8.49 | -5.57 | Upgrade
|
| EBIT Margin | -18.77% | -27.75% | -78.65% | -193.02% | - | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.